Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.

NCT04131322 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped Sponsor cancellation

Conditions

Crohn Disease
Ulcerative Colitis

Interventions

DRUG: Amgevita 40Mg Solution for Injection
DRUG: HUMIRA 40Mg Solution for Injection

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla